Pharma Reviews: ICICI Securities projects revenue growth of 6.3% of pharma segment in Q2

Indian pharma companies set to achieve recovery in revenue for the quarter ended September 2017 on account of improvement in domestic ...
Read more: ICICI Securities projects revenue growth of 6.3% of pharma segment in Q2